Dr. Mark Anstiss

Dr. Mark Anstiss

Head of Drug Substance Technical Services

About

Dr. Mark Anstiss has over 15 years of experience in the pharmaceutical and fine chemical and industries spanning Process Research and Development, Process Improvement, and Drug Substance manufacturing. Mark has a thorough understanding of the requirements for successful and safe scale up of chemical processes and has applied this knowledge to support the manufacture of early phase kilogram batches through to process improvement and optimization at tonne scale.  Throughout his career Mark has worked on the development and manufacturing of a significant number of psychoactive drug substances.  

Mark holds a Master of Chemistry degree from the University of Manchester and a PhD in Organic Chemistry from Leeds University.

Expertise & focus areas
Quotient Sciences Logo
Drug Substance

Drug Substance Synthesis and Manufacturing Info Sheet

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More